JPS6051176A - 新規イミダゾリン誘導体及びその製法 - Google Patents

新規イミダゾリン誘導体及びその製法

Info

Publication number
JPS6051176A
JPS6051176A JP59164160A JP16416084A JPS6051176A JP S6051176 A JPS6051176 A JP S6051176A JP 59164160 A JP59164160 A JP 59164160A JP 16416084 A JP16416084 A JP 16416084A JP S6051176 A JPS6051176 A JP S6051176A
Authority
JP
Japan
Prior art keywords
salt
phenyl group
compound
substituted phenyl
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59164160A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0542432B2 (https=
Inventor
Kazuo Matsumoto
松本　和男
Yoshiro Iwazawa
岩澤　義郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of JPS6051176A publication Critical patent/JPS6051176A/ja
Publication of JPH0542432B2 publication Critical patent/JPH0542432B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59164160A 1983-08-12 1984-08-03 新規イミダゾリン誘導体及びその製法 Granted JPS6051176A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8321719 1983-08-12
GB08321719A GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines

Publications (2)

Publication Number Publication Date
JPS6051176A true JPS6051176A (ja) 1985-03-22
JPH0542432B2 JPH0542432B2 (https=) 1993-06-28

Family

ID=10547197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59164160A Granted JPS6051176A (ja) 1983-08-12 1984-08-03 新規イミダゾリン誘導体及びその製法

Country Status (2)

Country Link
JP (1) JPS6051176A (https=)
GB (1) GB2144738A (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63108571A (ja) * 1986-10-24 1988-05-13 Mitsubishi Electric Corp ディジタル再生装置
JPS63313367A (ja) * 1987-06-15 1988-12-21 Mitsubishi Electric Corp デイジタル再生装置

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63108571A (ja) * 1986-10-24 1988-05-13 Mitsubishi Electric Corp ディジタル再生装置
JPS63313367A (ja) * 1987-06-15 1988-12-21 Mitsubishi Electric Corp デイジタル再生装置

Also Published As

Publication number Publication date
GB8321719D0 (en) 1983-09-14
JPH0542432B2 (https=) 1993-06-28
GB2144738A (en) 1985-03-13

Similar Documents

Publication Publication Date Title
JPS63280081A (ja) 置換イミダゾリル−アルキル−ピペラジンおよび−ジアゼピン誘導体
CS247073B2 (en) Production method of 2-substituted 4-amino-6,7-dimethoxyghinolins
JPH0236159A (ja) 化学化合物類
JPH0224821B2 (https=)
PT99794B (pt) Processo para a preparacao de novas piperazinas 1,4-dissubstituidas
JP3094384B2 (ja) 臨床医学で使用されるヒスタミン受容体ｈ３の新規な拮抗作用化合物と、その受容体の拮抗物質として作用する医薬組成物と、その製造方法
JPS6322082A (ja) １―（ヒドロキシスチリル）―５ｈ―２，３―ベンゾジアゼピン誘導体およびその製造方法、並びに前記誘導体を含む薬剤
HUT63610A (en) Process for producing immune modifying n-phenyl-2-cyano-3-hydroxycrotonic acid derivatives and pharmaceutical compositions comprising such compounds
JPH05140108A (ja) ピリジニルピペラジン誘導体
JPH06508375A (ja) インダン−１，３−ジオンおよびインダン−１，２，３−トリオンの誘導体、それらの調製方法およびそれらの治療上の使用
JP2000506874A (ja) 抗喘息性、抗アレルギー性、抗炎症性および免疫調節作用を有する１，３，５―トリ置換されたインダゾール誘導体
TW565559B (en) Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them
JPH02178263A (ja) アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
DE2427943A1 (de) Neue benzimidazole
JPS6051176A (ja) 新規イミダゾリン誘導体及びその製法
JP2726999B2 (ja) イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
JP2001511798A (ja) オキシド−スクアレンシクラーゼ抑制剤として有用な複素環化合物
TW200304823A (en) Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as medicament, and medicament containing them
JPS6112912B2 (https=)
US4025508A (en) 6-(Trifluoromethyl)-benzothiadiazines
AU634342B2 (en) Novel imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates
JPS62212386A (ja) ２−ピリジルメチルベンズイミダゾ−ル誘導体
JPH0662608B2 (ja) カルボスチリル誘導体
JP2678768B2 (ja) テトラヒドロイミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
JPH03284669A (ja) ４―フェニルフタラジン誘導体